men's health
PSA‑Only Protocols vs AI‑Enabled Risk Scoring - Which Path Fuels Early Detection of Prostate Cancer?
By 2035, the global prostate cancer diagnostics market is expected to reach $18 billion, reflecting rapid growth in screening technologies. Therefore, AI-enabled risk scoring fuels early detection more effectively than PSA-only protocols, because it combines multiple data streams to spot cancer sooner. Medical Disclaimer: This article is for informational purposes